WallStreetZenWallStreetZen

NASDAQ: VYNE
Vyne Therapeutics Inc Stock Ownership - Who owns Vyne Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vyne Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Tyler ZerondaCHIEF FINANCIAL OFFICER2025-03-318,399$1.58
$13.27kSell
David DomzalskiPRESIDENT AND CEO2025-03-3130,498$1.58
$48.19kSell
Mutya HarschCHIEF LEGAL OFFICER AND GC2025-03-318,828$1.58
$13.95kSell
Iain StuartCHIEF SCIENTIFIC OFFICER2025-03-316,044$1.58
$9.55kSell
Patrick G. LeporeDirector2025-01-1515,000$2.92
$43.80kBuy
Tyler ZerondaCHIEF FINANCIAL OFFICER2024-12-314,675$3.35
$15.66kSell
David DomzalskiPRESIDENT AND CEO2024-12-3124,536$3.35
$82.20kSell
Iain StuartCHIEF SCIENTIFIC OFFICER2024-12-314,857$3.35
$16.27kSell
Mutya HarschCHIEF LEGAL OFFICER AND GC2024-12-314,697$3.35
$15.73kSell
David DomzalskiPRESIDENT AND CEO2024-11-303,901$2.10
$8.19kBuy

1 of 2

VYNE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VYNE insiders and whales buy or sell their stock.

VYNE Shareholders

What type of owners hold Vyne Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC32.45%4,935,057$9.13MInsider
Vivo Capital VIII LLC26.37%4,011,236$7.42MInsider
Albert Cha26.37%4,011,236$7.42MInsider
Remeditex Ventures LLC18.16%2,761,663$5.11MInsider
Presidio Partners 2007 GP LP17.15%2,608,540$4.83MInsider
Venbio Global Strategic Fund II LP9.61%1,461,552$2.70MInsider
Cormorant Asset Management LP9.17%1,394,336$2.58MInstitution
Eventide Asset Management LLC9.17%1,394,336$2.58MInstitution
Merck Co Inc8.17%1,243,168$2.30MInsider
Citadel Advisors LLC8.09%1,230,457$2.28MInstitution

1 of 3

VYNE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VYNE21.30%78.70%Net SellingNet Selling
RADX0.02%0.00%
MLEC0.18%8.62%
CLGN11.12%0.00%
GBIO63.57%36.43%Net BuyingNet Selling
View Top Biotech Stocks

Vyne Therapeutics Stock Ownership FAQ

Who owns Vyne Therapeutics?

Vyne Therapeutics (NASDAQ: VYNE) is owned by 46.44% institutional shareholders, 171.56% Vyne Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Vyne Therapeutics shareholder, owning 4.94M shares representing 32.45% of the company. Perceptive Advisors LLC's Vyne Therapeutics shares are currently valued at $8.83M.

If you're new to stock investing, here's how to buy Vyne Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.